Eddy David
Health Aff (Millwood). 2007 Jul-Aug;26(4):w500-15. doi: 10.1377/hlthaff.26.4.w500. Epub 2007 Jun 19.
Evidence-based medicine (EBM) has increasingly influenced decision making in health policy and patient care. Appropriate use of EBM in decision making requires a clear understanding of the distinct "anatomical" components of all decisions: (1) scientific evidence and (2) judgments applied to that evidence by individuals or organizations. In this interview, Sean Tunis discusses these principles with David Eddy. Tunis has provided leadership at the national level in applying EBM principles to health policy decision making at the Office of Technology Assessment, the Centers for Medicare and Medicaid Services, and now the Center for Medical Technology Policy. Eddy is cofounder and medical director of Archimedes; he is widely recognized as a seminal contributor to evidence-based medicine, helping shape the initial ideas and applying them to guidelines, coverage policies, and performance measures.
循证医学(EBM)对卫生政策制定和患者护理决策的影响日益增大。在决策过程中恰当地运用循证医学,需要清楚地理解所有决策独特的“构成要素”:(1)科学证据,以及(2)个人或组织对该证据所做的判断。在本次访谈中,肖恩·突尼斯与大卫·埃迪探讨了这些原则。突尼斯在将循证医学原则应用于卫生政策决策方面,在国家层面发挥了引领作用,他曾任职于技术评估办公室、医疗保险和医疗补助服务中心,现在就职于医疗技术政策中心。埃迪是阿基米德公司的联合创始人兼医学总监;他被广泛认为是循证医学的开创性贡献者,帮助塑造了循证医学的最初理念,并将其应用于指南、医保覆盖政策和绩效评估标准。